Oxygen Therapy for Retinal Ischemia

Normobaric Nocturnal Hyperoxia Therapy for Treating Ischemic-Related Retinal Conditions

The investigators will be using nocturnal normobaric hyperoxia therapy in patients with diagnoses of conditions related to retinal ischemia.

Patients who receive a diagnosis of a condition relate to retinal ischemia and who pass the eligibility criteria will receive an oxygen concentrator to use at home. They will report back in follow up monthly for three to six months.

Inclusion Criteria:

• Diagnosis of retinal-ischemia related condition

Exclusion Criteria:

• Complicating other ocular condition
• History of smoking or lung conditions